Science-Based, Passion-Driven

We are advancing an innovative, high-value product portfolio for patients globally.

Learn More
doctor_and_patient

Passion with Purpose

We work to benefit patients wherever they live by uniting worldwide talent and resources with our vision.

Learn More
people_walking

Our Commitment to Patients

We offer resources to help patients and their loved ones navigate some of the complex challenges that follow the words, “You have cancer.”

Learn More
elder_women

BeiGene News

September 17, 2024

BeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA® for the Treatment of Oesophageal Squamous Cell Carcinoma (OSCC) After Prior Chemotherapy

Read more

September 9, 2024

BeiGene Announces Updates to Commercial Leadership Team

Read more

September 9, 2024

BeiGene Highlights TEVIMBRA® Data in Lung and Gastrointestinal Cancers at ESMO 2024

Read more

August 28, 2024

BeiGene to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

Read more

August 26, 2024

BeiGene’s BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL

Read more

August 7, 2024

BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates

Read more